Innovate UK

StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors. This technology aims to enhance the effectiveness of cancer treatments such as radiotherapy and chemotherapy by addressing tumor hypoxia, a significant clinical challenge. F

LinkGevity is an drug discovery company that focuses on life span and diseases associated with aging.

Lant Medical operates as a health tech company.

Lant Medical operates as a health tech company.

3D printing is revolutionizing healthcare and Axial3D is at the forefront of this innovation with a vision to make 3D printing a part of mainstream medical practice. They create precise, patient-specific 3D printed models generated directly from patient CT and MRI scan data. 3D printed models facilitate a better understanding of abnormalities, encourage novel surgical techniques and improve the surgical outcome for patients. Providing a unique Online Ordering Portal to securely upload scans in minutes, their expert team use the latest 3D printing technology to create precise physical 3D printed models of your patient’s anatomy and deliver directly to the consultant.

MediMusic is a health technology company that focuses on developing a medical technology platform aimed at alleviating pain, anxiety, and stress through the power of music. The platform leverages artificial intelligence to generate personalized playlists tailored to individual patient needs. By using soothing music, MediMusic's solution aims to lower heart rates and stimulate the vagus nerve, promoting a positive physiological response. This innovative approach not only helps in managing stress and anxiety but also enhances the effectiveness of pain medication, offering a holistic treatment option for patients dealing with various health challenges, including dementia and anxiety-related disorders.

LaennecAI is a clinical AI company that focuses on chronic disease management solutions.

Myogenes provides psychiatric tests, heredity cancer tests, and mental health mind maps.

Kaydiar is an innovative medical device company that specializes in offloading technology, we are committed to innovating superior products for cost-effective wound care, such as orthotic devices, bed mattresses, wheelchair cushions and prosthetic sleeves.

Epitopea is a biotechnology company focused on developing innovative immunotherapies for cancer treatment by targeting a new class of tumor-specific antigens. The company employs a proprietary approach that combines immunopeptidomics, mass spectrometry, genomics, and bioinformatics to identify conserved, aberrantly expressed tumor-specific antigens hidden within cancer's non-coding DNA. This technology aims to create therapies that effectively eliminate malignant cells while minimizing damage to healthy tissue, thereby reducing side effects and providing lasting benefits for patients. Research conducted by Drs. Claude Perreault and Pierre Thibault at the Institute for Research in Immunology and Cancer at Université de Montréal has been instrumental in the discovery of these novel antigens, known as Cryptigen™ TSAs, which are shared among patients with the same cancer type.

Lentitek is a biotechnology company focused on developing gene and gene-modified cell therapies, particularly aimed at treating cancer. The company is dedicated to enhancing the accessibility of innovative cures by increasing the yield of lentiviral vectors, which are critical for gene therapy applications. Lentitek employs a proprietary method that utilizes a novel promoter to significantly boost lentiviral production, potentially increasing yields by tenfold or more. This innovative approach not only improves the efficiency of lentivirus production but also aims to reduce overall production costs for healthcare providers, thereby facilitating broader availability of advanced therapeutic options for patients.

BoobyBiome is a company focused on improving infant health through microbiome research. It specializes in developing probiotic supplements specifically designed for infants with compromised microbiomes, particularly those born prematurely. By recreating the beneficial bacteria associated with breast milk, BoobyBiome aims to support healthy infant development. The company is also working on formula milk probiotics to create a substitute that closely resembles breast milk, allowing infants to receive the essential bacteria that contribute to their gut health and immune system.

SynaptixBio is a biotechnology company focused on developing innovative therapies for severe leukodystrophies, a group of rare genetic disorders affecting the brain's white matter. The company aims to disrupt existing treatment practices by creating a therapy that addresses the root cause of these diseases, specifically targeting the mutated TUBB4a gene implicated in TUBB4a Leukodystrophy. By leveraging groundbreaking research, SynaptixBio is dedicated to providing potentially curative options for patients suffering from this acute subset of leukodystrophies. The company also maintains an online platform to engage with customers and address inquiries, ensuring transparency and accessibility of information about their advancements.

Naitive is a population health company focused on improving patient care through AI-enabled clinical pathways and medical device technology. The company develops software that employs artificial intelligence, clinical data, and digital interventions to enhance the identification, treatment, and coordination of care for chronic diseases. By leveraging advanced computational capabilities, Naitive aims to support clinicians in transforming patient care while simultaneously reducing costs, time, and the failure rates commonly associated with chronic disease management.

Siloton is a medical device manufacturer focused on creating diagnostic imaging devices for ophthalmology. The company specializes in developing advanced portable optical coherence tomography devices designed to address challenges in eye care. Their hand-held sub-surface imaging technology allows for home-based scanning, providing users with the ability to monitor their eye health and contribute to the prevention of avoidable blindness.

Cumulus Neuroscience develops an AI-based digital biomarker platform to aid in the resolution of the most pressing healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience's platform is intended to provide the critical data and insight required for more rapid, robust, and cost-effective clinical trials that improve patient access to new therapies. The platform's novel insights change the future of clinical trials in brain disorders, allowing life-changing therapies to reach patients faster and more affordably.

KYMIRA is an e-commerce company specializing in smart garments and textiles designed to enhance athletic performance and overall well-being. The company develops innovative products that utilize compression fabric combined with infrared and sensor technology. These garments harness and recycle the energy generated by athletes, aiming to improve performance, address chronic health issues, reduce injury risks, and enhance sleep quality. Additionally, KYMIRA's products provide valuable data insights for both men and women, enabling sports enthusiasts to optimize their training and recovery processes.

LIfT BioSciences is a biotechnology company based in London, England, founded in 2016. The company specializes in a novel allogeneic innate immuno-cell therapy platform known as Neutrophil Only Leukocyte Infusion Therapy (N-LIfT). This platform enables the large-scale production of Immunomodulatory Alpha Neutrophils (IMANs) derived from induced pluripotent stem cells (iPSCs) for various therapeutic applications. LIfT BioSciences focuses on developing CAR neutrophil cell therapies that address the limitations of existing treatments for solid tumors. These therapies work by directly attacking tumors and indirectly enhancing the immune response, effectively transforming the tumor microenvironment to recruit additional immune cells for a more robust and lasting attack on the cancer. By employing proprietary enhancement media and genetic engineering, LIfT BioSciences aims to significantly increase the cancer-fighting capabilities of these engineered cells, potentially providing patients with greatly improved therapeutic outcomes.

SleepCogni is focused on developing innovative sleep aid technology that facilitates a personalized wind-down process to enhance sleep quality. The company's device, activated manually, utilizes sensors worn on the user's index finger to monitor key physiological and behavioral indicators, including heart rate, mental alertness, skin temperature, and movement. By employing cognitive behavioral therapy through biofeedback—delivered via visual, auditory, and tactile cues—SleepCogni aims to help users relearn healthy sleep patterns. This approach is designed to assist individuals in overcoming insomnia and improving their overall sleep cycle, offering a tailored solution to address common sleep challenges.

Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.

machineMD is a medical device company based in Switzerland, with a subsidiary in Boston, that focuses on advancing the fields of neuroscience and ophthalmology. The company aims to enhance the measurement of brain function, striving for timely and accurate diagnoses of brain disorders. By collaborating with a global network of clinical and research partners, machineMD seeks to extend the diagnostic capabilities of specialized medical practitioners to primary and secondary care settings. Its innovative automated device replaces traditional, manual assessments of eye movements and pupillary function, allowing medical assistants to conduct faster and more objective examinations. This technology provides ophthalmologists and neurologists with reliable measurements, ultimately improving patient care in the diagnosis of neurological conditions.

Graphene Trace is a company to help wheelchair users and hospitals prevent against pressure ulcers.

Cumulus Neuroscience develops an AI-based digital biomarker platform to aid in the resolution of the most pressing healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience's platform is intended to provide the critical data and insight required for more rapid, robust, and cost-effective clinical trials that improve patient access to new therapies. The platform's novel insights change the future of clinical trials in brain disorders, allowing life-changing therapies to reach patients faster and more affordably.

Presymptom Health develops a portfolio of clinical decision support algorithms and blood tests to enable early intervention and transform critical care outcomes.

Cortirio specializes in the development of portable brain imaging technology aimed at diagnosing and monitoring traumatic brain injuries, which are a leading cause of death and disability among individuals under 40. The company's innovative portable scanners utilize near-infrared imaging with enhanced spatial resolution to deliver point-of-care medical imaging. This technology enables healthcare providers to access vital information throughout the clinical pathway, facilitating automatic analysis and data transfer. By providing timely and accurate diagnostic capabilities, Cortirio's devices empower clinicians to make quicker decisions, ultimately improving care for patients suffering from brain injuries and strokes.

IXICO is a UK-based company specializing in clinical trial services and technology focused on imaging endpoints for the pharmaceutical and biotechnology sectors. The company primarily operates in the fields of oncology and neurology, offering end-to-end imaging services that cater to various therapeutic areas, including Alzheimer's, Parkinson's, Huntington's disease, and other neurodegenerative conditions. IXICO supports clients throughout the entire clinical research journey, providing services for early and late-phase clinical development, post-marketing assessments, and consultancy. With a presence in multiple countries, including the United States, Switzerland, the Netherlands, and Ireland, IXICO collaborates with pharmaceutical companies, academia, and medical charities to advance the treatment of complex diseases.

SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.

SökerData is a biotechnology company that provides research, and data analysis solutions for disease-related datasets.

Cyted Health specializes in developing a digital diagnostic infrastructure aimed at the early detection of diseases, particularly cancer. By leveraging artificial intelligence and innovative biomarkers, Cyted's platform enhances clinical insights and facilitates improved patient outcomes. The company's mission is to transform diagnostic methodologies, focusing on prevention rather than treatment, thereby contributing to a healthcare landscape where diseases are identified and addressed at their earliest stages.

CellRev is a biotechnology company specializing in innovative bioprocessing technologies aimed at improving cell manufacturing for various applications, including cultured meat, cell therapy, and biologics. The company's proprietary technology enables a shift from traditional batch processing to continuous processing of adherent cells, significantly enhancing yield while reducing operating costs and capital expenditures. CellRev's unique cell detachment process, combined with a specially designed bioprocess, addresses critical challenges in manufacturing, such as cell aggregation, clumping, and detachment. This approach allows cell-based vaccine and therapy developers to streamline their production processes, eliminate serum usage, and overcome significant bottlenecks in the industry.

BelleVie is a provider of personal care services aimed at supporting individuals in their daily lives while enabling them to maintain their independence. The company offers a range of services, including personal care, meal preparation, home assistance, social engagement, and specialized care. BelleVie operates with a unique model of self-managing teams, inspired by the successful Buurtzorg approach from the Netherlands, which emphasizes fulfilling careers in care and fosters meaningful relationships within the care ecosystem. The company utilizes its proprietary Wellbeing OS technology platform to facilitate its operations, funded through a monthly subscription model. BelleVie’s vision focuses on creating a society where every individual is valued and supported, ensuring that care providers and recipients alike benefit from reciprocal and enriching interactions.

SynaptixBio is a biotechnology company focused on developing innovative therapies for severe leukodystrophies, a group of rare genetic disorders affecting the brain's white matter. The company aims to disrupt existing treatment practices by creating a therapy that addresses the root cause of these diseases, specifically targeting the mutated TUBB4a gene implicated in TUBB4a Leukodystrophy. By leveraging groundbreaking research, SynaptixBio is dedicated to providing potentially curative options for patients suffering from this acute subset of leukodystrophies. The company also maintains an online platform to engage with customers and address inquiries, ensuring transparency and accessibility of information about their advancements.

Brainomix Limited, established in 2010 as a spin-out from the University of Oxford, develops advanced imaging biomarkers and software solutions aimed at enhancing clinical decision-making for neurological and cerebrovascular disorders. The company's flagship product, e-Stroke, employs state-of-the-art artificial intelligence algorithms to automate the interpretation of brain scans, specifically for acute ischemic stroke patients. This tool assists physicians in identifying and quantifying early stroke damage, thereby facilitating timely and informed treatment decisions. In addition to e-Stroke, Brainomix offers other software products such as e-ASPECTS, which automates the Alberta Stroke Program Early CT Score, and e-CTA, which standardizes the assessment of large vessel occlusion locations. These innovative solutions address the critical need for rapid and consistent evaluations of brain CT scans, ultimately optimizing patient outcomes and ensuring that stroke patients receive appropriate care in a timely manner. The company is headquartered in Oxford, United Kingdom.

Jude is a healthcare company focused on addressing bladder health issues and raising awareness about incontinence. The organization offers a range of services that include expert advice from medical professionals through social media, virtual seminars, and private chat options. Additionally, Jude provides health products designed to assist individuals in managing their bladder health effectively. By combining educational resources with accessible support, Jude aims to empower individuals to understand their medical conditions and pursue solutions for a leak-free life.

AstronauTx is a biotechnology company focused on developing treatments for Alzheimer's disease and other neurodegenerative conditions. The company aims to restore the normal functioning of astrocytes, which are crucial cells in the brain that support neuronal activity, metabolism, and the integrity of the blood-brain barrier. In conditions such as dementia, astrocytes can become dysfunctional, leading to neurotoxicity and exacerbating disease progression. By targeting astrocyte homeostasis, AstronauTx seeks to enable healthcare professionals to effectively address the underlying mechanisms of neurotoxicity associated with these diseases, ultimately improving treatment options for patients suffering from dementia and related disorders.

Corryn Biotechnologies is a biotechnology company focused on innovating wound care solutions through its Heals device, which offers a contactless method for treating chronic and complex wounds. The company has developed advanced applicators that utilize electrical voltages to extrude fine fibers from various fluids, creating wound dressings that can be made from synthetic or natural materials. These dressings can be enhanced with or without active ingredients and are designed to deposit non-woven meshes for effective Advanced Tissue Repair (ATR). Through this technology, Corryn aims to improve the management and healing of chronic wounds, providing a novel approach to wound dressing.

Kalium Health Ltd is a company focused on improving kidney care through innovative medical technology. Based in Cambridge, United Kingdom, it designs and manufactures a finger-prick blood test specifically for measuring blood potassium concentration. This test aims to facilitate early treatment for patients, reducing the complications and costs associated with traditional testing methods. By leveraging advanced electrolyte sensing technology, Kalium Health provides patients with accurate, real-time data essential for managing cardiorenal diseases. The company’s first product addresses a significant risk in kidney disease, a condition that imposes substantial financial burdens on healthcare systems. With a clear regulatory pathway and a targeted market strategy, Kalium Health is poised to transform patient care and enhance outcomes for millions affected by kidney disease.

Autolomous Ltd, founded in 2019 and based in Mayfair, United Kingdom, specializes in developing software solutions for manufacturers of cell and gene therapies. Its flagship platform, autoloMATE®, is a cloud-native system that provides comprehensive support for Advanced Therapies and Vector manufacturing processes. The software facilitates the scheduling of patient cell collections, the transport of these cells to production sites, and the tracking of manufacturing processes to ensure compliance with regulatory standards. It also supports the legal release and timely delivery of patient-specific medicines. The highly configurable platform allows clients to customize workflows and integrates seamlessly with existing systems. Autolomous emphasizes data security by utilizing blockchain technology to maintain the integrity of manufacturing data. The company adheres to strict regulatory guidelines and has achieved several ISO certifications, reflecting its commitment to quality management and environmental standards.

CalmBrain is a digital platform that provides psychological intervention for schools to assist students in managing their mental health, including anxiety, stress, and trauma.

Kids Speech Labs is a digital health company focused on transforming the delivery of speech and language therapy services through innovative technology. The company develops AI-driven solutions that include remote monitoring tools and interactive speech and language games. These resources empower parents to track their children's speech development effectively. By leveraging artificial intelligence, Kids Speech Labs aims to enhance the therapeutic experience, making it more accessible and engaging for children and their families.

Juniver offers specialized care and support for individuals recovering from eating disorders through a neuroscience-based recovery program. The company provides an on-demand platform that includes practical tools and habit-formation principles, aimed at helping users manage cravings and urges. By fostering a supportive community, Juniver facilitates long-term recovery, addressing the complexities of disordered eating in a comprehensive manner.

Life with Zeal a lifestyle brand that is revolutionizing the assisted living market.

Boost Innovations focuses on developing products specifically for women, with a particular emphasis on enhancing comfort and confidence. The company specializes in creating breast prostheses designed to provide both security and usability for users, especially those who have undergone surgery. Their innovative breast forms are crafted to remain secure within post-surgery underwear and are suitable for various activities, including swimming and exercising. By prioritizing breathability and functionality, Boost Innovations aims to meet the unique needs of its customers, ensuring they feel comfortable and confident in their daily lives.

The Allergy Team assists families, companies, and educational institutions in managing food allergies.

Orthonika Limited, established in 2014 and based in London, United Kingdom, specializes in the development and manufacturing of MenisciKnit, an anatomical meniscus replacement designed to address severe meniscus injuries. These injuries can significantly impair mobility and lead to complications such as osteoarthritis and the need for knee arthroplasty. Current treatment options, including partial meniscectomy and allograft transplantation, often fall short, leaving a significant unmet need in the market. MenisciKnit employs a unique fiber-reinforced material structure that closely mimics the natural meniscus, aiming to restore proper knee biomechanics. This innovative approach not only provides a solution for those with severe meniscus damage but also supports patients in resuming active lifestyles and offers a comprehensive alternative to traditional knee-related treatments.

InsideOut is a London-based company that focuses on mental health care and well-being support. It has developed a therapy platform aimed at reducing social stigma surrounding mental health and fostering open conversations about the subject. The platform provides continuous therapy support through an online application, which employs an intelligent matching system to connect users with suitable therapists. This approach enables individuals to maintain positive mental well-being by accessing tailored therapeutic resources and support.

Neu Health develops a smartphone-based clinical platform designed to deliver personalized care for individuals with Parkinson's disease and dementia. Utilizing cutting-edge digital technologies and artificial intelligence, the platform monitors and interprets digital indicators of clinically relevant symptoms. This approach aims to enhance condition management, alleviate the workload on clinicians, and ultimately improve patient outcomes. By enabling clinicians and caregivers to provide more efficient and effective care, Neu Health addresses the growing challenges faced by those managing these complex neurological conditions.

Care Reality are a hybrid of EdTech and HealthTech building a new reality for learning.

Lindus Health is a clinical research organization focused on delivering comprehensive clinical trial services for health and biotech companies. The company offers a range of solutions, including ethics and IRB submission, trial monitoring, data management, biostatistics, regulatory support, and payer affairs. By utilizing a proprietary software platform, Lindus Health automates various aspects of the clinical trial workflow, which streamlines operations and minimizes manual inefficiencies. This platform also facilitates access to electronic health records, enhancing patient recruitment and clinical data capture. Furthermore, Lindus Health leverages real-world patient data to improve trial design and execution, ultimately aiming to accelerate the clinical trial process while reducing risks and costs associated with trial failures.

Senisca is a biotech start-up. They propose to create a new generation of oligonucleotide-based interventions to rewind the clock in old cells and target diseases and cosmetic signs of aging. They provide molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence.

Vitarka Therapeutics develops medical technology and solutions for various types of cancer. It is based in London, United Kingdom.

Calla Lily Clinical Care is a women’s health-focused B-Corp that has created the proprietary Callavid® platform for intravaginal drug delivery. The company targets fertility and pregnancy with its innovative drug-device combination product aimed at preventing miscarriages and providing support during the luteal phase of In Vitro Fertilization (IVF). Additionally, Callavid® is designed to deliver live biotherapeutics to address recurrent Bacterial Vaginosis, thereby reducing antibiotic use and mitigating the spread of antimicrobial resistance. Other applications include hormone replacement therapy for menopause and the Lilyvid™ device, which facilitates advanced medical sample collection for biomarker-based diagnostics related to endometriosis and various other health conditions. The technology behind these devices has been recognized as a TIME Magazine Best Invention of the Year.

Doctoria is a virtual healthcare platform to enable doctors and patients to connect better.

Lightox specializes in developing advanced molecular tools for imaging, therapeutics, and assay development, focusing on innovative cancer treatments. The company has created a range of light-activated drug compounds designed to selectively target and eliminate tumor cells while minimizing harm to surrounding healthy tissue. Their unique fluorescent probes are smaller than any other products currently available, allowing for versatile applications in research and clinical settings. These probes can function as freely-moving agents that easily integrate into cells, or they can be customized with flexible linkers to meet specific research requirements. Lightox aims to enhance patient outcomes by providing more efficient cancer treatment options.

PatientMpower specializes in remote monitoring solutions aimed at patients with chronic diseases, particularly those with respiratory conditions. The company develops applications that integrate with devices such as spirometers and pulse oximeters, allowing patients to conduct measurements at home. These devices connect to a smartphone application, which transmits real-time data to healthcare providers. This integration supports healthcare professionals in delivering high-quality care and enhances patient outcomes by facilitating continuous monitoring. Additionally, the data collected contributes to research efforts aimed at improving treatment options for chronic conditions.

Myma Medical is a bright, cutting-edge start-up with a model to greatly improve the experiences of people who are having fertility issues.

KYMIRA is an e-commerce company specializing in smart garments and textiles designed to enhance athletic performance and overall well-being. The company develops innovative products that utilize compression fabric combined with infrared and sensor technology. These garments harness and recycle the energy generated by athletes, aiming to improve performance, address chronic health issues, reduce injury risks, and enhance sleep quality. Additionally, KYMIRA's products provide valuable data insights for both men and women, enabling sports enthusiasts to optimize their training and recovery processes.

BelleVie is a provider of personal care services aimed at supporting individuals in their daily lives while enabling them to maintain their independence. The company offers a range of services, including personal care, meal preparation, home assistance, social engagement, and specialized care. BelleVie operates with a unique model of self-managing teams, inspired by the successful Buurtzorg approach from the Netherlands, which emphasizes fulfilling careers in care and fosters meaningful relationships within the care ecosystem. The company utilizes its proprietary Wellbeing OS technology platform to facilitate its operations, funded through a monthly subscription model. BelleVie’s vision focuses on creating a society where every individual is valued and supported, ensuring that care providers and recipients alike benefit from reciprocal and enriching interactions.

Healthera operates a comprehensive healthcare marketplace in the UK, connecting patients with medicines, healthcare services, and products through a vast digital platform that includes both national pharmacy chains and independent providers. The company's technology facilitates quicker medicine delivery and personalized medical care tailored to individual needs. By reinventing the pharmacy operating model, Healthera enhances patient communication, encourages cross-sales, and fosters customer loyalty. The company is dedicated to digitizing and automating primary care processes, which improves prescribing efficiency and the overall patient experience while minimizing waste for the NHS. Partnering with over 1,000 pharmacies and clinical commissioning groups, Healthera reaches more than 20 million individuals. Its technology is accredited by NHS Digital, positioning Healthera as one of the fastest-growing digital health firms in Europe. Headquartered in Cambridge, the company boasts a diverse international team committed to improving healthcare delivery through human-centered technology.

NIQS Tech is a quantum technology spin-out from the University of Leeds that is focused on delivering truly non-invasive, continuous, and accurate glucose monitoring technologies - diabetes management with no needles or blood. Accessible, user-friendly glucose monitors will provide actionable insights and enable effective diabetes management. Ultimately, NIQS aims to empower people living with diabetes to live happier and healthier lives by removing the need for cumbersome glucose management technologies and reducing their risk of diabetes-related complications.

Brainstem is a DePIN to collect and utilise wearable health data. Our mission is to revolutionize healthcare and improve lives through remote screening, ongoing monitoring, digital treatment alternatives, and tools to share data with practitioners, researchers, and others. We are committed to building a network of users who are willing to share their data and embracing collaboration with smart minds to speed innovation. With our vision of being a 24/7 virtual health assistant specializing in sleep, mental, cardio, and neuro health, we are at the forefront of digital health.

The National Biofilms Innovation Centre (NBIC) is the central hub where academia, industry, government, and public policy come together to tackle the grand challenges biofilms present, impacting ~$5 trillion in global economic activity, from food and health to ships, clean water and energy. Funded by the BBSRC, Innovate UK and Hartree Centre, our mission is to establish a network of research and innovation capacity to catalyse partnerships with industry to achieve breakthrough innovations and impact – from industry products and solutions to services and spinouts. We aim to bring together researchers and industry to explore unmet needs and exchange ideas, problems and solutions through roadmaps, workshops and conferences. We plan to invest in future scientists through our PhD and Post-Doc programs, and entrepreneurial training, to grow their expertise, help them better understand the commercial environment and encourage new start-ups.

Ascentys provides digital health business services.

PocketEye is a cloud-based platform that enables secure communication between primary and secondary eye care, ensuring seamless referrals and enabling remote specialist triaging for eye care. For optometrists, GPs, and hospital eye services, PocketEye can enhance a patient’s journey from community to hospital, ensuring patient safety is the central focus.

Neurovirt is a company focused on enhancing movement rehabilitation through the use of immersive virtual reality and artificial intelligence. It develops AI-driven games that facilitate both gamification and quantification of rehabilitation exercises, making high-intensity therapy accessible in clinical settings and at home. These innovative games incentivize patients to engage in their rehabilitation process, aiming to improve health outcomes significantly. By utilizing sensor technology, Neurovirt enables healthcare professionals to monitor patient progress accurately, whether remotely or onsite, while also offering insights into recovery predictions.

Libereat is a technology company specializing in allergen detection software aimed at enhancing food safety for businesses. Its machine learning software identifies dangerous errors in food data that traditional safety processes often overlook. By analyzing food labeling, packaging, supplier information, ingredient lists, and supply chain data, Libereat enables large brands to automatically detect and address potential issues before products reach consumers. This proactive approach helps prevent harm to consumers while mitigating significant costs, regulatory challenges, and reputational damage for food businesses.

Acurable Limited is a MedTech start-up based in London that specializes in the design and commercialization of a wearable sensor-based health care device aimed at diagnosing and managing respiratory conditions in a non-invasive manner. The company's flagship product, AcuPebble, allows for the diagnosis of sleep apnea and the monitoring of various respiratory and cardiac conditions through advanced algorithms that analyze acoustic signals. This technology, which emerged from a decade of research at Imperial College London, provides more accurate readings than existing solutions, significantly reducing the risk of misdiagnosis. AcuPebble is designed for home use, requiring no specialist training, which helps lower healthcare costs. Acurable's mission is to gain a comprehensive understanding of human biosignals to ensure that treatable conditions do not result in preventable deaths.

Drill Surgeries empowers doctors operating on 20 million broken bones to reduce their 36% failure rate to <4% with Artificial Intelligence. Their AI-powered navigation system transforms trauma and orthopaedic procedures: 83% reduction in OR time Eliminate ALL unnecessary X-rays Save hospitals $2,000 per operation

Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics, with the goal of addressing the rising issue of antimicrobial resistance.

Nolea Health is a jobs marketplace platform specifically designed for mental healthcare, addressing the growing shortage of healthcare staff. Its AI-powered platform matches verified mental health professionals with open positions at healthcare organizations. Its platform addresses the issue of workforce shortages, reduces costly and inefficient hiring processes, and increases flexibility and job satisfaction for all NHS clinical staff.

BoobyBiome is a company focused on improving infant health through microbiome research. It specializes in developing probiotic supplements specifically designed for infants with compromised microbiomes, particularly those born prematurely. By recreating the beneficial bacteria associated with breast milk, BoobyBiome aims to support healthy infant development. The company is also working on formula milk probiotics to create a substitute that closely resembles breast milk, allowing infants to receive the essential bacteria that contribute to their gut health and immune system.

BoobyBiome is a company focused on improving infant health through microbiome research. It specializes in developing probiotic supplements specifically designed for infants with compromised microbiomes, particularly those born prematurely. By recreating the beneficial bacteria associated with breast milk, BoobyBiome aims to support healthy infant development. The company is also working on formula milk probiotics to create a substitute that closely resembles breast milk, allowing infants to receive the essential bacteria that contribute to their gut health and immune system.

Transdermal Diagnostics is a technology platform to improve the prevention, diagnosis, and management of chronic conditions with diabetes.

On The Mend is a mobile platform to help people manage their physical rehab. We are currently working towards creating a unique platform with a broad application beyond orthopaedic surgery.

Stemnovate Limited is a biotechnology company based in Cambridge, United Kingdom, founded in 2016. It specializes in providing innovative tools and technologies for drug screening and safety testing. Its offerings include induced pluripotent stem cells, human and multispecies primary cells, and a comprehensive cell culture and analysis package. The company utilizes advanced devices such as micro physiological systems and microfluidic designs to enhance drug discovery. One of its notable projects, "Liver on chip," focuses on liver toxicity testing and incorporates techniques like cellular reprogramming and organ-on-chip technology. Stemnovate also offers services in cell reprogramming, differentiation, and application development, catering to a diverse clientele that includes pharmacists, contract research organizations, small to medium enterprises, and academic institutions.

OKKO Health specializes in developing home-monitoring applications for eye health, utilizing advanced algorithms that integrate vision science, computer science, and game technology. Their software allows patients at high risk for eye diseases to monitor their eyesight from home, promoting early detection and personalized care. By enabling self-assessment between clinical appointments, OKKO Health aims to enhance patient engagement and streamline appointment scheduling. The company’s innovative approach combines scientific research with practical applications in clinical practice and drug development, providing a reliable method for measuring vision and predicting potential deterioration in eye health.

At OCUWELL, we're revolutionising eye care with our innovative, cloud-based solutions designed to make quality eye care accessible and affordable for everyone, everywhere. Our flagship product is a portable corneal topographer addressing the global need for essential diagnostic tools in treating corneal disorders, which affect over 2.2 billion people. With a unique B2B and SaaS business model, backed by 25 years of leading scientific research, we're on track to transform the delivery of eye care worldwide.

Awakn Life Sciences is a biotechnology company dedicated to developing and delivering psychedelic medicine aimed at treating addiction, with a primary focus on Alcohol Use Disorder (AUD). The company's team comprises chemists, scientists, psychiatrists, and psychologists who are working on the next generation of psychedelic drugs and therapies. By addressing AUD, a condition that affects millions worldwide and for which existing treatments are often insufficient, Awakn seeks to provide innovative therapeutic solutions for individuals struggling with addiction.

PhysioMedics is a healthcare technology company focused on enhancing the management of musculoskeletal disorders through its online software solutions. The company has developed a self-assessment platform that offers data analytics, personalized self-help advice, and information to connect back pain sufferers with appropriate treatment pathways. This approach enables patients to take an active role in their healthcare, leading to improved outcomes. Additionally, PhysioMedics' platform assists organizations in reducing costs associated with absenteeism and enhances overall efficiency in managing musculoskeletal conditions.

Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics, with the goal of addressing the rising issue of antimicrobial resistance.

Senisca is a biotech start-up. They propose to create a new generation of oligonucleotide-based interventions to rewind the clock in old cells and target diseases and cosmetic signs of aging. They provide molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence.

NRG Therapeutics is a drug discovery company established in 2018 that specializes in developing therapeutic approaches aimed at restoring mitochondrial function to address neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, and motor neuron disease. The company focuses on creating novel medicines that preserve mitochondrial function and halt disease progression. With a team experienced in neuroscience drug discovery, NRG Therapeutics is initially concentrating on the discovery and development of brain-penetrant inhibitors of the mitochondrial permeability transition pore specifically for Parkinson’s disease. This strategic focus is intended to empower physicians with effective treatment options for patients suffering from chronic neurodegenerative disorders.

BoobyBiome is a company focused on improving infant health through microbiome research. It specializes in developing probiotic supplements specifically designed for infants with compromised microbiomes, particularly those born prematurely. By recreating the beneficial bacteria associated with breast milk, BoobyBiome aims to support healthy infant development. The company is also working on formula milk probiotics to create a substitute that closely resembles breast milk, allowing infants to receive the essential bacteria that contribute to their gut health and immune system.

We already know that upto 50% of patients struggle to take their medicines – patients are not well-supported and too often it remains a hidden problem until it's too late. CONNECT Care want to change that: empowering patients and, at the same time, using data-driven insights to enable clinicians and carers to provide better support in real-time.

For expectant & new parents, Anya is the best tool to support you through your early parenthood & breastfeeding journey. Anya is here to support you with credible & expert guidance every step of the way, using unique LatchAid™ 3D interactive breastfeeding animations, the Anya virtual supporter answering your questions 24/7, real-life experts ready to help, & close-knit communities where you can connect with other parents. Whether you have questions about pregnancy, birth, latching, combination feeding, pumping, cluster feeding, milk supply, reflux, sleep, nappies, going back to work or more, Anya offers peer-to-peer support & professional assistance. Giving you confidence to be the parent you want to be, so you don’t feel exhausted, frustrated or in pain. Anya is an easy-to-use app for parenting & breastfeeding support, including: LatchAid™ 3D breastfeeding tool: * Interactive animations to help you learn breastfeeding skills visually. * Camera responds to your touch & shows you how to position your baby at the breast, using your desired angles & X-ray mode to see inside the baby’s mouth. * Demonstrating different breastfeeding positions, accompanied by audio & subtitles. * Personalise breast sizes & skin tones to represent you & your baby. Anya AI virtual supporter: support anytime, anywhere: * Providing parents with personalised support & companionship, 24/7, worldwide. * Answers all your questions regarding infant feeding, baby care, pregnancy, & parental health. * Our knowledge base is constantly evolving based on hundreds of questions from parents like you worldwide. * Access 1-1 support from our real-life experts on anything about mother & baby wellbeing, or parental health to get credible, evidence-based answers. Peer support communities: * It takes a village to raise a child. Connect with other parents to share knowledge & experience, to create lasting friendships & access help through in-app virtual chat groups. Parenting & breastfeeding support: * Access the knowledge base of top experts with internationally-recognised qualifications. * Tailored insight page to your baby's age & stage. * Explore articles, videos & FAQs related to your current stage 24/7. * Join in with our in-app events or watch them back to suit you. Interactive expert webinars: * Connect with qualified infant feeding, baby care, & parental health experts in weekly webinars & drop-in Q&A sessions. * Get professional advice in a supportive environment, all from the comfort of your own home. Why download Anya? * Anya is the only breastfeeding & early parenthood support app powered by empathy & innovation. * Downloaded & trusted by 1000s of parents around the world. * You can learn to breastfeed confidently with our help. Solves a problem 90% of new mothers face, due to pain, lack of support & faltering confidence with breastfeeding. * Recommended by the NHS in the UK, so you know it’s high quality. * An innovative & complementary solution to traditional breastfeeding support that offers AI virtual supporter, 1-to-1 specialist support, & a peer community to empower parents to give their child the best start in life. * We build the confidence of mothers to achieve their infant feeding goals with animations, peer community, 24/7 specialist support & personalised AI companion. As soon as you become a parent, you have questions, lots of them! Anya and LatchAid™ were developed by specialists who work with parents every day to help them reach their parenting & breastfeeding goals. Many mothers of newborn babies give up breastfeeding less than three months after birth, due to physical pain, frustration & anxiety. We are here to help support you with empathy & companionship and to answer all of your 3am worries. We believe that every parent deserves the support & empowerment to give their child the best start in life. Together we nurture.

Paranimo is focused on enhancing workplace mental health by providing accessible and effective support solutions. The company employs advanced matching intelligence within its software-as-a-service (SaaS) and consulting offerings, aimed at helping HR managers improve employee well-being. By connecting clients with therapists across the United Kingdom, Paranimo's technology enables therapists to evaluate and rank mental health conditions they can address, thereby creating a percentage match with potential clients. This approach facilitates convenient access to therapy sessions, promoting increased mental health awareness and support in the workplace.

BIOStress is a company focused on enhancing the understanding and management of stress through innovative technology. It has developed a proprietary algorithm that accurately measures stress levels using data from existing biometric devices. By leveraging this technology, BIOStress offers a platform that objectively monitors workplace stress, providing employees with personalized insights into their stress levels. This approach not only aims to improve individual well-being but also enhances overall productivity within organizations. By focusing on the balance between well-being and stress management, BIOStress seeks to foster healthier work environments and better performance outcomes.

Medwise.ai offers a customizable search platform designed to support clinical decision-making for healthcare professionals. Utilizing natural language processing and artificial intelligence, the platform enables doctors to efficiently access and organize medical knowledge. By leveraging real-world data, Medwise.ai provides valuable intelligence and insights to various stakeholders within the healthcare ecosystem. This innovative approach aims to enhance the professional capabilities of doctors, ultimately improving patient care and outcomes.

Neurovirt is a company focused on enhancing movement rehabilitation through the use of immersive virtual reality and artificial intelligence. It develops AI-driven games that facilitate both gamification and quantification of rehabilitation exercises, making high-intensity therapy accessible in clinical settings and at home. These innovative games incentivize patients to engage in their rehabilitation process, aiming to improve health outcomes significantly. By utilizing sensor technology, Neurovirt enables healthcare professionals to monitor patient progress accurately, whether remotely or onsite, while also offering insights into recovery predictions.

Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.

Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population. Cytochroma’s automated cell manufacture, physiologically relevant models and rapid screening platform makes preclinical testing faster, safer and smarter.

Vamstar operates a B2B healthcare supply chain platform that addresses inefficiencies in the sourcing and procurement processes for medical devices and pharmaceuticals. By utilizing advanced data automation technologies such as machine learning, Vamstar aggregates demand from millions of sources, creating a comprehensive marketplace that connects buyers, including hospitals and health systems, with a vast network of suppliers. The platform provides real-time analytics and valuable tools for search and bid development, allowing users to quickly identify suitable opportunities and finalize transactions. With access to a significant volume of global demand and millions of contracts, Vamstar simplifies the procurement process, helping healthcare organizations reduce costs and improve access to essential products and services. The company is dedicated to building a digital marketplace that fosters innovation in healthcare and is supported by leading investors in the field.

Armour Labs is an insurtech startup focused on providing employers and insurers with digital health solutions. It supports better access to healthcare by leveraging technology to streamline processes and improve outcomes.

SleepCogni is focused on developing innovative sleep aid technology that facilitates a personalized wind-down process to enhance sleep quality. The company's device, activated manually, utilizes sensors worn on the user's index finger to monitor key physiological and behavioral indicators, including heart rate, mental alertness, skin temperature, and movement. By employing cognitive behavioral therapy through biofeedback—delivered via visual, auditory, and tactile cues—SleepCogni aims to help users relearn healthy sleep patterns. This approach is designed to assist individuals in overcoming insomnia and improving their overall sleep cycle, offering a tailored solution to address common sleep challenges.

Calla Lily Clinical Care is a women’s health-focused B-Corp that has created the proprietary Callavid® platform for intravaginal drug delivery. The company targets fertility and pregnancy with its innovative drug-device combination product aimed at preventing miscarriages and providing support during the luteal phase of In Vitro Fertilization (IVF). Additionally, Callavid® is designed to deliver live biotherapeutics to address recurrent Bacterial Vaginosis, thereby reducing antibiotic use and mitigating the spread of antimicrobial resistance. Other applications include hormone replacement therapy for menopause and the Lilyvid™ device, which facilitates advanced medical sample collection for biomarker-based diagnostics related to endometriosis and various other health conditions. The technology behind these devices has been recognized as a TIME Magazine Best Invention of the Year.

We already know that upto 50% of patients struggle to take their medicines – patients are not well-supported and too often it remains a hidden problem until it's too late. CONNECT Care want to change that: empowering patients and, at the same time, using data-driven insights to enable clinicians and carers to provide better support in real-time.

Paranimo is focused on enhancing workplace mental health by providing accessible and effective support solutions. The company employs advanced matching intelligence within its software-as-a-service (SaaS) and consulting offerings, aimed at helping HR managers improve employee well-being. By connecting clients with therapists across the United Kingdom, Paranimo's technology enables therapists to evaluate and rank mental health conditions they can address, thereby creating a percentage match with potential clients. This approach facilitates convenient access to therapy sessions, promoting increased mental health awareness and support in the workplace.

Rinri Therapeutics Limited is a biotechnology company based in Sheffield, United Kingdom, focused on developing regenerative stem cell-based therapies to treat hearing loss. Founded in 2018, the company specializes in advanced stem cell technology that aims to repair damaged or dead sensory cells in the inner ear, specifically targeting sensorineural hearing loss. By restoring the cytoarchitecture of the inner ear, Rinri Therapeutics seeks to enable medical professionals to effectively restore hearing for affected patients.

Glamorous AI develops an artificial intelligence-based drug discovery platform that focuses on low-data scenarios in pharmaceutical research. The platform utilizes AI to identify and optimize novel chemical compounds, facilitating the discovery of new medicines by analyzing prior experimental results. It is designed to handle sparse, noisy, and small datasets, making it particularly effective for tackling complex drug discovery challenges. By leveraging a large repository of pre-trained and customizable AI models, Glamorous AI enables researchers to screen extensive chemical libraries and address novel and first-in-class therapeutic targets, ultimately driving innovation in drug development and contributing to the advancement of treatments for various diseases.

Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking. The kits offered by Bea Fertility include an intracervical insemination device, as well as pregnancy tests, fertility trackers, and sperm donation pots. Bea Fertility democratizes effective and affordable fertility treatment for individuals and couples who are having difficulty conceiving.